DEF 14AThe Ballot
BridgeBio Pharma, Inc. files DEF 14A
Filed Apr 24, 2026 · 2mo ago · Accession 0001140361-26-016723
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- BridgeBio Pharma, Inc.
- Ticker
- BBIO
- CIK
- 1743881
- Form type
- DEF 14A
- Filing date
- Apr 24, 2026
- Report date
- Jun 22, 2026
- Document
- ny20065754x1_def14a.htm
- Size
- 7.9 MB